Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing ...
Iranian Foreign Minister Abbas Araghchi accused the U.S. and Israel of "direct involvement" in his country's ongoing ...
CrowdStrike's 2025 data shows attackers breach AI systems in 51 seconds. Field CISOs reveal how inference security platforms ...
USDCHF gained above 0.8000 after mixed US jobs data.It touched an intraday high of 0.80175and is now trading at 0.80157. The ...
M+ cash runway to 2029, bitopertin FDA NDA/accelerated approval catalyst, and DISC-0974 myelofibrosis data—read now.
Preliminary Preclinical Data Demonstrates In Vivo Proof-of-Concept for Novel Diabetes Gene Therapy in Type 2 Diabetic Non-Human Primates GPX-002 Rejuvenated Exhausted ...
Released today, January 9, 2026, the U.S. Bureau of Labor Statistics stated a disappointing +50,000 non-farm payroll jobs ...
Steeper-than-expected December mortgage lock volume drop as seasonality, shutdown uncertainty, and stubborn rates keep ...
Meta is rated a Strong Buy, with current valuation dislocation driven by accounting noise and misunderstood CapEx cycles.
Drake faces RICO lawsuit as new data reveals illegal gambling captured $38.7 billion of US online market in 2025—74% of ...
Opinion
Zacks Investment Research on MSNOpinion
Top research reports for NVIDIA, Alphabet & Amazon.com
Friday, January 9, 2026 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corp.
Goldman Sachs (GS) reports Q4 earnings Jan 15. BofA raises price target to $1,050, citing long-term EPS growth despite ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results